Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
290 studies found for:    APOA1
Show Display Options
Rank Status Study
1 Completed Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients
Condition: Diabetes
Interventions: Drug: Rosuvastatin;   Drug: Placebo
2 Recruiting Theobromine, Vascular Function and Intestinal apoA-I Production
Condition: Cardiovascular Disease
Interventions: Dietary Supplement: Theobromine;   Dietary Supplement: Placebo drink
3 Completed Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
4 Completed The Effects of Fat and Theobromine on apoA-I
Condition: Cardiovascular Diseases
Interventions: Dietary Supplement: Fat  milkshake;   Dietary Supplement: Theobromine
5 Completed Resveratrol and Serum Apo A-I
Condition: Dyslipidemia
Intervention: Dietary Supplement: Resveratrol capsules
6 Unknown  Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes
Condition: Type 2 Diabetes Mellitus Without Insulin Treatment
Interventions: Drug: simvastatin/ezetimibe;   Drug: atorvastatin 20mg
7 Completed
Has Results
ROMEO (Rosuvastatin in Metabolic syndrOme)
Condition: Metabolic Syndrome X
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
8 Completed Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study
Condition: Atherogenic Dyslipidemia
Interventions: Drug: Lipitor;   Drug: ABT335;   Drug: Niaspan
9 Completed Propofol and Perioperative Inflammation
Condition: Inflammation
Interventions: Drug: propofol;   Drug: Intralipid 10%;   Drug: Saline
10 Completed ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Condition: Coronary Artery Disease
Interventions: Drug: RVX000222;   Drug: Placebo RVX000222
11 Terminated High Density Lipoprotein Turnover
Condition: Obesity
Interventions: Drug: Placebo;   Drug: Rimonabant
12 Completed
Has Results
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease
Condition: Diabetes Mellitus
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
13 Completed Apolipoprotein A-I Gene Polymorphism and Atherosclerosis
Conditions: Coronary Arteriosclerosis;   Cardiovascular Diseases;   Heart Diseases;   Atherosclerosis
14 Completed
Has Results
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
15 Unknown  Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)
Condition: HDL Cholesterol
Interventions: Drug: Simvastatin;   Drug: Atorvastatin 80 mg
16 Completed
Has Results
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
Conditions: Primary Hypercholesterolemia;   Dyslipidemia
Interventions: Drug: Pitavastatin;   Drug: Atorvastatin
17 Recruiting Effects of High Fruit, Vegetable, and Dairy Intake on Plasma Lipids and Blood Pressure in Healthy Individuals
Conditions: Cardiovascular Disease;   Dyslipidemia;   Blood Pressure
Intervention: Other: Dietary Intervention
18 Terminated
Has Results
Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)
Conditions: Hypertriglyceridemia in Type 4 Hyperlipidemia;   Non Diabetic Subjects With Normoglycemia
Interventions: Drug: Rosiglitazone;   Drug: Placebo (Rosiglitazone);   Drug: Placebo (Fenofibrate);   Drug: Fenofibrate
19 Terminated Nicotinic Acid Composition of HDL and Arterial Endothelium Function in Premature Coronary Heart Disease and High HDL
Condition: Dyslipidemias
Interventions: Drug: Nicotinic acid;   Drug: Placebo
20 Completed
Has Results
PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin
Condition: Familial Hypercholesterolemia
Interventions: Drug: Rosuvastatin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years